ctDNA Identifies CRC Patients Who Benefit From Adjuvant Therapy ctDNA Identifies CRC Patients Who Benefit From Adjuvant Therapy
A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Expert Disagree on Adding Chemo to Targeted Drugs in EGFR+ NSCLC Expert Disagree on Adding Chemo to Targeted Drugs in EGFR+ NSCLC
Two expert analyses arrive at opposite conclusions about adding chemotherapy to targeted drugs in patients with EGFR+ metastatic non –small cell lung cancer (mNSCLC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Potential New Standard of Care for Biliary Tract Cancer Potential New Standard of Care for Biliary Tract Cancer
Interim data from a large phase 3 trial show that adding durvalumab to chemotherapy significantly improved overall survival vs chemotherapy alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 24, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adding Immunotherapy to Chemo Ups Survival in Advanced Biliary Tract Cancer
MONDAY, Jan. 24, 2022 -- Adding the immunotherapeutic agent durvalumab to standard chemotherapy improves survival in advanced biliary tract cancer, according to a study presented at the annual American Society of Clinical Oncology Gastrointestinal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2022 Category: Pharmaceuticals Source Type: news

Adjuvant Chemo Should Be Used in Gynecologic Carcinosarcoma Adjuvant Chemo Should Be Used in Gynecologic Carcinosarcoma
Patients with gynecologic carcinosarcoma benefit from adjuvant chemotherapy following surgery, even if they have early-stage disease, indicates a"very important '" analysis of registry data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer treatment may inhibit immune response to COVID-19 vaccination
JACKSONVILLE, Fla. — A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy ― and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells ― may mount an inadequate immune response to COVID-19 vaccination. The findings are publ ished in Mayo Clinic Proceedings: Innovation, Quality& Outcomes. "It is important for patients with cancer who are receiving chemotherapy to receive a COVID-19 vaccine," says… (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - January 20, 2022 Category: Hospital Management Source Type: news

Could Probiotics Reduce'Chemo Brain' in Breast Cancer Patients? Could Probiotics Reduce'Chemo Brain' in Breast Cancer Patients?
Patients with breast cancer reported fewer symptoms of cognitive impairment associated with chemotherapy when they took a probiotics supplements, reports the first study of its kind.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Combo Therapy for Breast Implant –Associated Lymphoma New Combo Therapy for Breast Implant –Associated Lymphoma
Women who develop breast implant –associated anaplastic large-cell lymphoma can achieve good outcomes with chemotherapy plus brentuximab vedotin.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 18, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mother, 36, devastated after terminal lung cancer diagnosis
Becky Davis, 36, from Redditch, was blindsided in July 2020 when doctors revealed that her symptoms were down to a rare form of cancer, which chemotherapy is not effective against. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2022 Category: Consumer Health News Source Type: news

Omit Periop Chemo in Mismatch Repair Deficient Gastric Cancer Omit Periop Chemo in Mismatch Repair Deficient Gastric Cancer
Patients with mismatch repair deficient gastric cancer demonstrated better median overall survival when skipping perioperative chemotherapy, according to a preprint study.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
This study offers a reasonable chance of benefit. It would be nice to see if these patients again respond to immunotherapy.” The FDA approved Opdivo and Yervoy, an immunotherapy combination, for first-line treatment of pleural mesothelioma in 2020. It was the first new systemic approval in more than 16 years. However, it only increased the median overall survival time from 14.1 months to 18.1 months, when compared to standard chemotherapy. Find Immunotherapy Clinical Trials Learn how to access mesothelioma clinical trial...
Source: Asbestos and Mesothelioma News - January 4, 2022 Category: Environmental Health Authors: Chris Elkins Source Type: news

' Outstanding' Outcomes: Reduced Radiation in Oropharynx Cancer'Outstanding' Outcomes: Reduced Radiation in Oropharynx Cancer
Comparable progression-free survival was observed in intermediate-risk patients with HPV and oropharynx cancer who received less intense postoperative radiation therapy, without chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pembrolizumab +/- Chemotherapy: Reading Between the Studies Pembrolizumab +/- Chemotherapy: Reading Between the Studies
Dr Mark Kris discusses how to read between the studies to determine optimal treatments for patients when clinical trial data are not available.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Former WebMD Editor Kristy Hammam Dies
The cause of her death was triple-negative breast cancer. She was 50 years old. Hammam retired from a 22 year career at WebMD in June of 2021, after losing much of her eyesight to chemotherapy. (Source: WebMD Health)
Source: WebMD Health - December 24, 2021 Category: Consumer Health News Source Type: news

Triple Therapy for Squamous NSCLC Shows Real-World Clinical Benefit Triple Therapy for Squamous NSCLC Shows Real-World Clinical Benefit
Sintilimab immunotherapy is not only effective when combined with gemcitabine and chemotherapy, but it may be a novel option when added to paclitaxel/nab-paclitaxel in squamous non –small cell lung cancer.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New PET tracer emerging in primary prostate cancer staging
An experimental prostate cancer PET radiotracer looks promising detecting suspecte...Read more on AuntMinnie.comRelated Reading: New radiotracer improves management of prostate cancer patients When to biopsy: How prostate MRI can transform best practice PSMA-PET predicts patient response to chemotherapy PSMA-PET agent could aid prostate cancer patients Could Ga-68 PSMA PET become essential for prostate cancer? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 23, 2021 Category: Radiology Source Type: news

Triple Therapy for HER2-Positive Gastric Cancer Shrinks Tumors Triple Therapy for HER2-Positive Gastric Cancer Shrinks Tumors
The addition of pembrolizumab (Keytruda) to trastuzumab (Herceptin) and platinum-based chemotherapy led to a significant improvement in overall response rate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Novel Agents for Adult ALL: Is it Curtains for Chemo? Novel Agents for Adult ALL: Is it Curtains for Chemo?
Tyrosine kinase inhibitors and novel agents like bi-specific T-cell engager and antibody drug conjugates have diminished the need for chemotherapy in adults with acute lymphoblastic leukemia (ALL).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UCLA gene therapy gives new life to girl born with fatal immune disorder
In every visible way, Marley Gaskins is an average 12-year-old — she enjoys painting, playing online games like Roblox with her friends and taking ukulele lessons. But until recently, her life was far from normal.Marley was born with a one-in-a-million genetic disorder called leukocyte adhesion deficiency-1, or LAD-1, which cripples the immune system and results in recurring infections, coupled with slow wound healing.“She started getting what looked like ant bites on her skin when she turned 1,” said Marley’s mother, Tamara Hogue. “When she was 3, she got a really big skin abscess on her stom...
Source: UCLA Newsroom: Health Sciences - December 17, 2021 Category: Universities & Medical Training Source Type: news

Tumor-Associated Collagen Signature Helps Predict Gastric Cancer Prognosis Tumor-Associated Collagen Signature Helps Predict Gastric Cancer Prognosis
The level of tumor-associated collagen signature of gastric cancer may help predict which patients are likely to benefit from adjuvant chemotherapy, research from China suggests.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 17, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Postmenopausal Women With Early Breast Cancer Can Go Chemo-Free Postmenopausal Women With Early Breast Cancer Can Go Chemo-Free
The RxPONDER trial also highlighted the benefits of chemotherapy only in premenopausal women with breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Drug Combo May Fight a Tough Form of Breast Cancer
WEDNESDAY, Dec. 15, 2021 -- An experimental drug, added to chemotherapy, may benefit women with an aggressive form of breast cancer, suggests an early study offering much-needed good news. The study involved women with " triple-negative " breast... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 15, 2021 Category: General Medicine Source Type: news

Drug combo shows promise in patients with advanced or metastatic breast cancer, study finds
A new drug combination is effective at slow disease progression in people with advanced or metastatic breast cancer resistant to conventional chemotherapy, a study published by Science Translational Medicine found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 15, 2021 Category: Consumer Health News Source Type: news

Drug Can Keep Leukemia in Remission for Years in Younger Patients
New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. (Source: WebMD Health)
Source: WebMD Health - December 14, 2021 Category: Consumer Health News Source Type: news

TKI/BiTE Combo Extends Survival of Older Patients With Ph+ALL TKI/BiTE Combo Extends Survival of Older Patients With Ph+ALL
Estimated 3-year disease-free survival and overall survival rates topped 80% in elderly patients with Philadelphia-chromosome-positive ALL not amenable to chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

21-Gene Assay Guides Chemotherapy in Node-Positive Breast Cancer
TUESDAY, Dec. 14, 2021 -- Premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer with one to three positive lymph nodes and a recurrence score of 25 or lower benefit from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2021 Category: Pharmaceuticals Source Type: news

Ibrutinib, (brand name Imbruvica), Can Keep Leukemia in Remission for Years in Younger Patients
TUESDAY, Dec. 14, 2021 -- For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL).... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 14, 2021 Category: General Medicine Source Type: news

AGILE:'Exciting' Survival Results for IDH1-mutated AML AGILE:'Exciting' Survival Results for IDH1-mutated AML
Older patients not eligible for intensive chemotherapy had higher complete remission rates and longer overall survival when ivosidenib was added onto azacitidine in the AGILE phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Remarkable' Results With CAR T Cells Could Make Chemo Obsolete'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete
Chemotherapy, the decades-old approach to second-line therapy for relapsed/refractory large B cell lymphomas, may soon be obsolete, investigators say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 11, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Clinical and Real-World Data Support Use of DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma
ATLANTA, Ga., December 11, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX® (daratumumab)-based regimens may be able to achieve, including a potential survival benefit for DARZALEX® in combination with lenalidomide and dexamethasone (Rd). Updated data from the randomized Phase 2 GRIFFIN study in transplant-eligible patients and real-world evidence in transplant-ineligible patients were presented at the American Society of Hematology (ASH) 2021 Annual Meeting. Data from the GRIFFIN study will also b...
Source: Johnson and Johnson - December 11, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Clinical Trials Lead to Promising Updates in Mesothelioma Immunotherapy
This study recruited patients with unresectable pleural mesothelioma who had not received prior chemotherapy. The primary endpoint of median overall survival was significantly longer with the addition of bevacizumab to chemotherapy at 18.8 months versus 16.1 months with chemotherapy alone. However, adverse events such as hypertension and bleeding were more common in the bevacizumab group. More recently, studies such as the phase II RAMSES trial in 2020 have shown promising results for combining anti-VEGF medication with chemotherapy as a second-line treatment. The addition of the VEGF inhibitor ramucirumab significan...
Source: Asbestos and Mesothelioma News - December 8, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Mesothelioma Clinical Trial to Involve Drug Studied for COVID-19
A novel phase II clinical trial for malignant mesothelioma is expected to open soon and involve a versatile, biological drug already showing promise in treating severe cases of COVID-19. Oncotelic Therapeutics Inc., an innovative, immunotherapy/oncology company in Agoura Hills, California, hopes to open the mesothelioma clinical trial by March at a dozen prominent U.S. treatment centers, including the Cleveland Clinic Cancer Center, University of Pennsylvania Medicine in Philadelphia and Fred Hutchinson Cancer Research Center in Seattle. “We’re excited about the potential. There is a huge unmet medical ne...
Source: Asbestos and Mesothelioma News - December 7, 2021 Category: Environmental Health Authors: Chris Elkins Source Type: news

HEALTH NOTES: Robot 'fish' could be used to deliver chemotherapy drugs directly into tumours
The robots, one-hundredth of a millimetre in size, were made my Chinese scientists using a special 3D printing technique, from a gel that changes shape when exposed to different pH levels. (Source: the Mail online | Health)
Source: the Mail online | Health - December 4, 2021 Category: Consumer Health News Source Type: news

FDA Approves Rituximab for Multiple Pediatric Cancers FDA Approves Rituximab for Multiple Pediatric Cancers
The Food and Drug Administration approved rituximab in combination with chemotherapy for the treatment of pediatric patients with 4 different types of previously untreated, advanced stage blood cancers.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA approves rituximab plus chemotherapy for pediatric cancer indications
Oncology / Hematology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 3, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Breast Cancer: Test Reveals Who Can Skip Chemo After Surgery
For decades, chemotherapy has been used after breast cancer surgery when the cancer has spread to nearby lymph nodes. (Source: WebMD Health)
Source: WebMD Health - December 3, 2021 Category: Consumer Health News Source Type: news

Study: COVID-19 vaccines less effective in some cancer patients receiving chemotherapy, but better than nothing
COVID-19 vaccines offer less protection in people with cancer undergoing chemotherapy, but are still better than no protection at all, a study published Thursday by JAMA Oncology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 2, 2021 Category: Consumer Health News Source Type: news

B. Braun Medical Launches Next Generation OnGuard(R) 2 CSTD
Designed to provide simple, safe, and easy-to-use protection for healthcare workers BETHLEHEM, Pa., Dec. 2, 2021 -- (Healthcare Sales & Marketing Network) -- B. Braun Medical Inc., a leading provider of closed system transfer devices (CSTD), announced ... Devices, Product Launch B. Braun Medical, OnGuard 2, CSTD, chemotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2021 Category: Pharmaceuticals Source Type: news

FDA Rejects Novel Agent for Chemo-induced Neutropenia FDA Rejects Novel Agent for Chemo-induced Neutropenia
The agency said that more clinical data is needed for the novel agent plinabulin for use in the prevention of chemotherapy-induced neutropenia.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 2, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New radiotracer improves management of prostate cancer patients
PET imaging with the radiotracer F-18 DCFPyL detects more metastatic tumor...Read more on AuntMinnie.comRelated Reading: PSMA-PET predicts patient response to chemotherapy How can the clinical potential of PET/MRI be unlocked? PET/MRI bests MRI alone for detecting recurrent prostate cancer Prostate cancer imaging tracers evaluated head-to-head SNMMI updates appropriate use criteria for PSMA PET (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 2, 2021 Category: Radiology Source Type: news

Adjuvant Atezo in Stage II/IIIA Lung Cancer: A New Standard? Adjuvant Atezo in Stage II/IIIA Lung Cancer: A New Standard?
Dr Mark Kris discusses a recent trial demonstrating improved disease-free survival for patients with resected stage II to IIIA, PD-L1-positive lung cancer treated with atezolizumab following cisplatin-based chemotherapy.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)
NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the“Company” or“BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced it... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 1, 2021 Category: Drugs & Pharmacology Source Type: news

Janssen Seeks Approval of IMBRUVICA ®(ibrutinib) in a Fixed-Duration Regimen for Patients with Untreated Chronic Lymphocytic Leukaemia (CLL)
BEERSE, BELGIUM, 30 November 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Type II variation application to the European Medicines Agency (EMA) seeking approval of a new treatment option for IMBRUVICA® (ibrutinib) as a fixed-duration combination with venetoclax (I+V) for adult patients with previously untreated chronic lymphocytic leukaemia (CLL)."Ibrutinib was the first approved Bruton’s tyrosine kinase inhibitor and over the past seven years has become a key treatment for CLL and some other B-cell malignancies, treating more than 250,000 pati...
Source: Johnson and Johnson - November 30, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Study Explores if a Vaccine Can Prevent Breast Cancer
Harnessing the immune system to target cancer has long resided on doctors’ wish lists, with very little promise of becoming reality. Because cancer cells are normal cells that mutate to grow out of control, directing the body to destroy these cells is a risky endeavor with potentially dangerous outcomes. Advances in immunotherapy, however, have led to powerful drugs that can help immune cells better distinguish between cancer cells and healthy ones, and researchers are now testing the idea of whether the immune system can be trained to recognize and destroy breast cancer cells in the same way that it dispatches virus...
Source: TIME: Health - November 29, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthscienceclimate Source Type: news

Too many firefighters are dying of cancer. UCLA ’s Derek Urwin aims to change that
They ’re our modern-day superheroes — charging into burning buildings without hesitation, rescuing those in peril, staving off destruction. Butin risking their lives for us, firefighters pay a heavy price, with cancer rates that far outpace the public at large.Derek Urwin, a longtime firefighter who expects to complete his Ph.D. in chemistry during the winter quarter, is out to change that, using his knowledge of chemistry to  improve firefighter health and safety and, ultimately, bring these cancer rates down. It’s a mission that had a very personal origin.In 2014, Urwin ’s brother Isaac,...
Source: UCLA Newsroom: Health Sciences - November 22, 2021 Category: Universities & Medical Training Source Type: news

PSMA-PET predicts patient response to chemotherapy
PET imaging with a radiotracer based on prostate-specific membrane antigen (PSMA...Read more on AuntMinnie.comRelated Reading: PET/MRI bests MRI alone for detecting recurrent prostate cancer Prostate cancer imaging tracers evaluated head-to-head Telix applauds NCCN radiotracer update Ga-68 PSMA-11 improves outcomes in prostate cancer patients FDA makes history with approval of Ga-68 PSMA-11 PET (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 19, 2021 Category: Radiology Source Type: news

AstraZeneca Releases More Positive Data on COVID-19 Antibody Treatment
AstraZeneca Plc’s Covid-19 antibody cocktail was more than 80% successful at both preventing symptomatic disease and stopping the illness from worsening after six months, demonstrating its ability to provide long-lasting protection. The medicine reduced the risk of developing symptomatic Covid by 83% in one of the trials, after six months follow-up, the company said Thursday. The other, which was on half-year data from outpatient participants with mild-to-moderate illness, found the cocktail reduced the risk of severe disease or death by 88%. The results pointed to better protection than the initial data even as the ...
Source: TIME: Health - November 18, 2021 Category: Consumer Health News Authors: Suzi Ring/Bloomberg Tags: Uncategorized COVID-19 wire Source Type: news

Is Zytiga a Form of Chemotherapy?
Title: Is Zytiga a Form of Chemotherapy?Category: Diseases and ConditionsCreated: 11/17/2021 12:00:00 AMLast Editorial Review: 11/17/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 17, 2021 Category: Cancer & Oncology Source Type: news

Invasive pulmonary aspergillosis caused by Aspergillus terreus diagnosed using virtual bronchoscopic navigation and endobronchial ultrasonography with guide sheath and successfully treated with liposomal amphotericin B
Invasive aspergillosis is a significant cause of mortality in patients with hematological malignancy. Early diagnosis of invasive pulmonary aspergillosis (IPA) by bronchoscopy is recommended but is often difficult to perform because of small lesion size and bleeding risk due to thrombocytopenia. A 71-year-old woman had received initial induction therapy for acute myeloid leukemia. On day 22 of chemotherapy, she had a high fever, and the chest computed tomography scan revealed a 20-mm-sized nodule with a halo sign. Bronchoscopy assisted by virtual bronchoscopic navigation (VBN) and endobronchial ultrasonography with a guide...
Source: Current Awareness Service for Health (CASH) - November 12, 2021 Category: Consumer Health News Source Type: news

Chemotherapy With FOLFOX Superior to TACE in Liver Cancer Chemotherapy With FOLFOX Superior to TACE in Liver Cancer
Hepatic arterial infusion chemotherapy with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) in a randomized phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news